These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1466971)
1. Summary of the Antigenic Variation Working Group. Bradac J; Ho D AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1419-21. PubMed ID: 1466971 [No Abstract] [Full Text] [Related]
6. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866 [TBL] [Abstract][Full Text] [Related]
7. Diversity and variation in human immunodeficiency virus: implications for immune control. Ramsay AJ Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():215-21. PubMed ID: 1452223 [No Abstract] [Full Text] [Related]
8. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598 [TBL] [Abstract][Full Text] [Related]
9. Human antibodies to HIV-1 by recombinant DNA methods. Burton DR; Barbas CF Chem Immunol; 1993; 56():112-26. PubMed ID: 8452652 [No Abstract] [Full Text] [Related]
10. [Monoclonal anti-HIV antibodies in HIV/AIDS research. Diagnosis and therapy]. Giese R; Grunow R Allerg Immunol (Leipz); 1989; 35(1):25-37. PubMed ID: 2718887 [TBL] [Abstract][Full Text] [Related]
12. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937 [TBL] [Abstract][Full Text] [Related]
13. How does the HIV escape cytotoxic T cell immunity? Phillips RE; McMichael AJ Chem Immunol; 1993; 56():150-64. PubMed ID: 7680867 [No Abstract] [Full Text] [Related]
14. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection. Nara P; Smit L; Dunlop N; Hatch W; Merges M; Waters D; Kelliher J; Krone W; Goudsmit J Dev Biol Stand; 1990; 72():315-41. PubMed ID: 2282990 [TBL] [Abstract][Full Text] [Related]
15. Report of a WHO workshop on synthetic peptides in HIV diagnosis and AIDS-related research, Moscow 24-26 May 1989. World Health Organization Global Programme on AIDS. AIDS; 1991 Jan; 5(1):WHO1-9. PubMed ID: 1711860 [No Abstract] [Full Text] [Related]
16. Antibody polyspecificity and neutralization of HIV-1: a hypothesis. Haynes BF; Moody MA; Verkoczy L; Kelsoe G; Alam SM Hum Antibodies; 2005; 14(3-4):59-67. PubMed ID: 16720975 [TBL] [Abstract][Full Text] [Related]